June 2020 - Page 275 of 383

NASDAQ Companies - June 9, 2020

Chi-Med Announces US$95 million Guangzhou Land Compensation Agreement

LONDON, June 09, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that Hutchison Whampoa Guangzhou […]

TSX News - June 9, 2020

TransGlobe Energy Corporation Announces Its Participation in the Virtual Summer Summit

AIM & TSX: “TGL” & NASDAQ: “TGA”CALGARY, Alberta, June 09, 2020 (GLOBE NEWSWIRE) — TransGlobe Energy Corporation (“TransGlobe” or the […]

NASDAQ Companies - June 9, 2020

ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia

Patient enrollment completed; 50 patients in the trialEncouraging preliminary results based on interim dataUnmet medical need confirmed by FDALYON, France […]

NASDAQ Companies - June 8, 2020

Replimune Announces Pricing of Upsized Public Offering

BOSTON, June 08, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from […]

TSX News - June 8, 2020

Cequence Energy Announces Extension of Stay Period to September 8, 2020 and Scheduled Delisting From the Toronto Stock Exchange

CALGARY, Alberta, June 08, 2020 (GLOBE NEWSWIRE) — Cequence Energy Ltd. (“Cequence” or the “Company”) (TSX: CQE) announces that it […]

NASDAQ Companies - June 8, 2020

Retrophin Announces Pricing of Public Offering of Common Stock

SAN DIEGO, June 08, 2020 (GLOBE NEWSWIRE) — Retrophin, Inc. (Nasdaq: RTRX) today announced the pricing of an underwritten public […]

NASDAQ Companies - June 8, 2020

Kezar Announces Pricing of a Public Offering of $46.7 million of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 08, 2020 (GLOBE NEWSWIRE) — Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and […]